Antibiotic Resistance, Genotyping
Bacterial antibiotic resistance (ABR) occurs when bacteria are no longer responsive to the antibiotics used to treat the infections they cause. The increase in bacterial ABR has become a global problem as the number of bacterial harboring ABR is increasing.
Diagnostic testing for antibiotic resistance has historically been culture-based, where susceptibility testing is performed in conjunction with bacterial identification. The main disadvantage of culture based antibiotic susceptibility testing (which is considered phenotyping), is the time required to perform the testing. Depending on the microorganism, it may take 3-4 days to get results. Obtaining a pure culture is critical to the accuracy in identifying and looking for antibiotic resistance, as mixed cultures provide erroneous and uninterpretable results.
The advantages of genotypic ABR detection include: A) easy result interpretation as either; “present or not present” or “detected or not detected”. B) genotypic detection is not dependent upon phenotypic breakpoints for determining susceptibility vs. resistance as these may vary between countries. C) mechanisms involved in low‐level resistance may be difficult to detect using phenotypic methods. D) genetic assays can sometimes be performed directly on clinical specimens and bypass pathogen isolation by culture, this both reduces detection time, and is important for difficult‐to‐culture organisms. E) rapid results allow for early therapeutic intervention. F) genetic assays may reduce the biohazard risk associated with conventional culture methods.
On the other hand, the genotypic approach has certain limitations and pitfalls: A) genetic detection is based on screening for resistance determinants whereas decision making in antimicrobial therapy is preferably based on the detection of phenotypic susceptibility. B) genetic tests can only screen for markers that are already known, and genetic methods do not take into account new resistance mechanisms. C) there are silent genes and pseudogenes that may cause false‐positive results.
- As an aid in the diagnosis of bacterial infections
- Therapy selection and monitoring
Not Detected (Not Resistant)
Urine for urinary tract infection, vaginal swab for genital infection, variety of swabs for skin, throat or nasopharyngeal infection, variety of swabs from wound and other tissue specific swabs or body fluids.
Stability
Depends on the specimen type. Most of swabs and urine can be transported at room temperature and should be stored refrigerated. Sooner the specimens are processed better results.
- Enferm Infecc Microbiol Clin. 2017 Mar;35(3):182-188. [PMID: 28109552]
- J Hosp Infect. 2019 Aug;102(4):465-469. [PMID: 30905675]
- Microbiol Spectr. 2017 Dec;5(6). [PMID: 29219107]
- Clin Microbiol Rev. 2001 Oct;14(4):836-71. [PMID: 11585788]
- APMIS. 2004 Nov-Dec;112(11-12):815-37. [PMID: 15638839]
- Clin Microbiol. 2003 Sep;41(9):4089-94. [PMID: 12958230]